Dr. Siddhartha Yadav, MD

Dr. Yadav practices at Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic.

Dr. Yadav's NPI, 1306134143, was assigned on July 14, 2011. Dr. Yadav holds Minnesota license 62037.

Dr. Yadav's primary practice is Mayo Clinic Hospital, Saint Marys Campus, at 1216 Second Street Southwest, Rochester, MN 55902 in Olmsted County. The practice phone is (507) 255-5123.

Dr. Yadav's primary practice is Mayo Clinic Hospital, Saint Marys Campus in Rochester, Minnesota, part of Mayo Clinic. The medical group on file is Mayo Clinic. Dmand AI also links Dr. Yadav to 1 more hospice, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yadav practices, 2 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Yadav's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dmand AI has Dr. Yadav's licenses on file in 2 states: Minnesota and Michigan.

CMS data shows 8,381 Medicare services from Dr. Yadav across 16 procedure codes in 2024, for 179 Medicare patients. Medicare paid $223,507 for them. Every service was in an office.

CMS counts 179 Medicare patients who saw Dr. Yadav in 2024. The largest group is 65 to 74, with 99 patients. 59% of them have cancer, and 58% have high cholesterol. 10% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yadav's median patient age at 67, with 77% women.

In 2024, Dr. Yadav wrote 147 Medicare Part D claims for 31 patients. 88% of them were for generic drugs. CMS names the drug for 113 of them, across 5 drugs with 11 or more claims each, at $213,597 in total drug cost. In 2023, CMS named 39 claims across 2 drugs.

Dr. Yadav accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yadav as offering telehealth.

Dmand AI links 7 papers to Dr. Yadav, published from 2020 to 2025. 2025 was the busiest year, with 3. The most frequent topics are Breast Neoplasms, BRCA1 Protein and BRCA2 Protein. Dr. Yadav's most frequent co-authors are Susan M. Domchek, MD, Kathryn Jean Ruddy, MD, MPH and Antonis Antoniou, MD.

CMS Open Payments shows 12 general payments to Dr. Yadav from 5 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 96% of the total. AstraZeneca Pharmaceuticals LP paid the most, $13,997.